361 Capital LLC acquired a new position in shares of Masimo Corporation (NASDAQ:MASI) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 10,161 shares of the medical equipment provider’s stock, valued at approximately $880,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of MASI. Comerica Bank lifted its stake in Masimo Corporation by 4.8% in the third quarter. Comerica Bank now owns 37,054 shares of the medical equipment provider’s stock worth $3,218,000 after purchasing an additional 1,708 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in Masimo Corporation by 6.4% in the third quarter. Bank of New York Mellon Corp now owns 1,074,648 shares of the medical equipment provider’s stock worth $93,021,000 after purchasing an additional 64,882 shares during the last quarter. DekaBank Deutsche Girozentrale lifted its stake in Masimo Corporation by 78.3% in the third quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after purchasing an additional 925 shares during the last quarter. Rhumbline Advisers lifted its stake in Masimo Corporation by 18.7% in the third quarter. Rhumbline Advisers now owns 107,530 shares of the medical equipment provider’s stock worth $9,308,000 after purchasing an additional 16,953 shares during the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. lifted its stake in Masimo Corporation by 49.9% in the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 97,918 shares of the medical equipment provider’s stock worth $8,476,000 after purchasing an additional 32,575 shares during the last quarter. 84.70% of the stock is owned by institutional investors.

Several analysts have weighed in on MASI shares. BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Monday, August 14th. Stifel Nicolaus restated a “buy” rating and issued a $108.00 price objective (up previously from $105.00) on shares of Masimo Corporation in a research report on Thursday, August 3rd. Zacks Investment Research upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a research report on Thursday, November 2nd. Finally, BidaskClub cut shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $97.17.

In related news, EVP Yongsam Lee sold 13,976 shares of the business’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $89.43, for a total transaction of $1,249,873.68. Following the transaction, the executive vice president now owns 74,000 shares in the company, valued at $6,617,820. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total transaction of $900,000.00. Following the transaction, the director now owns 73,249 shares in the company, valued at approximately $6,592,410. The disclosure for this sale can be found here. Insiders have sold 28,976 shares of company stock worth $2,599,324 in the last quarter. 13.10% of the stock is owned by corporate insiders.

Masimo Corporation (NASDAQ:MASI) traded up $0.06 during mid-day trading on Monday, hitting $86.55. 205,500 shares of the company’s stock were exchanged, compared to its average volume of 626,198. Masimo Corporation has a 12-month low of $60.31 and a 12-month high of $104.71. The stock has a market capitalization of $4,470.00, a PE ratio of 33.16, a price-to-earnings-growth ratio of 2.92 and a beta of 0.74.

Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.53 by $0.17. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. The firm had revenue of $193.69 million for the quarter, compared to analysts’ expectations of $189.01 million. During the same quarter in the previous year, the company earned $0.52 earnings per share. The company’s revenue for the quarter was up 15.6% compared to the same quarter last year. equities research analysts anticipate that Masimo Corporation will post 2.95 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This report was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2017/11/20/361-capital-llc-takes-880000-position-in-masimo-corporation-masi.html.

Masimo Corporation Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.